The aim of the present study was to test this hypothesis by examining expression of Legumain in primary gastric cancers, normal mucosa, and lymph nodes metastasis, and to determine the relationships between Legumain expression and various clinicopathologic and biological variables. The gene discussed is LGMN; the disease is gastric cancer.